Search by Drug Name or NDC

    NDC 47335-0836-83 Galantamine Hydrobromide 16 mg/1 Details

    Galantamine Hydrobromide 16 mg/1

    Galantamine Hydrobromide is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is GALANTAMINE HYDROBROMIDE.

    Product Information

    NDC 47335-0836
    Product ID 47335-836_3ddec6e9-e082-4c2d-a026-aee87736ef80
    Associated GPIs 62051030107030
    GCN Sequence Number 058239
    GCN Sequence Number Description galantamine HBr CAP24H PEL 16 MG ORAL
    HIC3 J1B
    HIC3 Description CHOLINESTERASE INHIBITORS
    GCN 23606
    HICL Sequence Number 016520
    HICL Sequence Number Description GALANTAMINE HBR
    Brand/Generic Generic
    Proprietary Name Galantamine Hydrobromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Galantamine Hydrobromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 16
    Active Ingredient Units mg/1
    Substance Name GALANTAMINE HYDROBROMIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090178
    Listing Certified Through 2024-12-31

    Package

    NDC 47335-0836-83 (47335083683)

    NDC Package Code 47335-836-83
    Billing NDC 47335083683
    Package 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-836-83)
    Marketing Start Date 2011-02-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.43752
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GALANTAMINE ER 16 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis